<SEC-DOCUMENT>0000950123-21-010210.txt : 20210811
<SEC-HEADER>0000950123-21-010210.hdr.sgml : 20210811
<ACCEPTANCE-DATETIME>20210811065459
ACCESSION NUMBER: 0000950123-21-010210
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210630
FILED AS OF DATE: 20210811
DATE AS OF CHANGE: 20210811
EFFECTIVENESS DATE: 20210811
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERNATIONAL BIOTECHNOLOGY TRUST PLC
CENTRAL INDEX KEY: 0000942257
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-18673
FILM NUMBER: 211161914
BUSINESS ADDRESS:
STREET 1: 65 GRESHAM ST
CITY: LONDON
STATE: X0
ZIP: EC2V 7NQ
BUSINESS PHONE: 44 (0) 20 7421 7070
MAIL ADDRESS:
STREET 1: 65 GRESHAM ST
CITY: LONDON
STATE: X0
ZIP: EC2V 7NQ
</SEC-HEADER>
<DOCUMENT>
<TYPE>13F-HR
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?>
<edgarSubmission xsi:schemaLocation="http://www.sec.gov/edgar/thirteenffiler eis_13F_Filer.xsd" xmlns:ns1="http://www.sec.gov/edgar/common" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sec.gov/edgar/thirteenffiler">
<headerData>
<submissionType>13F-HR</submissionType>
<filerInfo>
<liveTestFlag>LIVE</liveTestFlag>
<flags/>
<filer>
<credentials>
<cik>0000942257</cik>
<ccc>XXXXXXXX</ccc>
</credentials>
</filer>
<periodOfReport>06-30-2021</periodOfReport>
</filerInfo>
</headerData>
<formData>
<coverPage>
<reportCalendarOrQuarter>06-30-2021</reportCalendarOrQuarter>
<isAmendment>false</isAmendment>
<filingManager>
<name>INTERNATIONAL BIOTECHNOLOGY TRUST PLC</name>
<address>
<ns1:street1>65 Gresham St</ns1:street1>
<ns1:city>London</ns1:city>
<ns1:stateOrCountry>X0</ns1:stateOrCountry>
<ns1:zipCode>EC2V 7NQ</ns1:zipCode>
</address>
</filingManager>
<reportType>13F HOLDINGS REPORT</reportType>
<form13FFileNumber>028-18673</form13FFileNumber>
<provideInfoForInstruction5>N</provideInfoForInstruction5>
</coverPage>
<signatureBlock>
<name>James Costine</name>
<title>Authorised Signatory</title>
<phone>0044 2074217081</phone>
<signature>James Costine</signature>
<city>London</city>
<stateOrCountry>X0</stateOrCountry>
<signatureDate>08-11-2021</signatureDate>
</signatureBlock>
<summaryPage>
<otherIncludedManagersCount>0</otherIncludedManagersCount>
<tableEntryTotal>67</tableEntryTotal>
<tableValueTotal>378776</tableValueTotal>
<isConfidentialOmitted>false</isConfidentialOmitted>
</summaryPage>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>INFORMATION TABLE
<SEQUENCE>2
<FILENAME>5379.xml
<DESCRIPTION>INFORMATION TABLE FOR FORM 13F
<TEXT>
<XML>
<informationTable xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sec.gov/edgar/document/thirteenf/informationtable">
<infoTable>
<nameOfIssuer>ACCELERON PHARMA INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>00434H108</cusip>
<value>7592</value>
<shrsOrPrnAmt>
<sshPrnamt>60500</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>60500</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Agios Pharmaceuticals Inc</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>00847X104</cusip>
<value>1185</value>
<shrsOrPrnAmt>
<sshPrnamt>21500</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>21500</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>ALKERMES PLC</nameOfIssuer>
<titleOfClass>SHS</titleOfClass>
<cusip>G01767105</cusip>
<value>1103</value>
<shrsOrPrnAmt>
<sshPrnamt>45000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>45000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>ALLAKOS INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>01671P100</cusip>
<value>1338</value>
<shrsOrPrnAmt>
<sshPrnamt>15700</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>15700</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Alnylam Pharmaceuticals Inc</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>02043Q107</cusip>
<value>25239</value>
<shrsOrPrnAmt>
<sshPrnamt>149000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>149000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Amgen Inc</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>031162100</cusip>
<value>12431</value>
<shrsOrPrnAmt>
<sshPrnamt>51000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>51000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Amicus Therapeutics Inc</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>03152W109</cusip>
<value>912</value>
<shrsOrPrnAmt>
<sshPrnamt>94600</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>94600</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>ANAPTYSBIO INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>032724106</cusip>
<value>259</value>
<shrsOrPrnAmt>
<sshPrnamt>10000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>10000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>APELLIS PHARMACEUTICALS INC</nameOfIssuer>
<titleOfClass>CM</titleOfClass>
<cusip>03753U106</cusip>
<value>1476</value>
<shrsOrPrnAmt>
<sshPrnamt>23400</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>23400</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>ARDELYX INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>039697107</cusip>
<value>591</value>
<shrsOrPrnAmt>
<sshPrnamt>78000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>78000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Arena Pharmaceuticals Inc</nameOfIssuer>
<titleOfClass>COM NEW</titleOfClass>
<cusip>040047607</cusip>
<value>1431</value>
<shrsOrPrnAmt>
<sshPrnamt>21000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>21000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Ascendis Pharma AS</nameOfIssuer>
<titleOfClass>Sponsored ADR</titleOfClass>
<cusip>04351P101</cusip>
<value>1815</value>
<shrsOrPrnAmt>
<sshPrnamt>13800</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>13800</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>AURINIA PHARMACEUTICALS INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>05156V102</cusip>
<value>3869</value>
<shrsOrPrnAmt>
<sshPrnamt>298500</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>298500</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>AXSOME THERAPEUTICS INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>05464T104</cusip>
<value>944</value>
<shrsOrPrnAmt>
<sshPrnamt>14000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>14000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Biogen Inc</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>09062X103</cusip>
<value>16794</value>
<shrsOrPrnAmt>
<sshPrnamt>48500</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>48500</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>BIOHAVEN PHARMACTL HLDG CO L</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>G11196105</cusip>
<value>17113</value>
<shrsOrPrnAmt>
<sshPrnamt>176400</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>176400</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Biomarin Pharmaceutical Inc</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>09061G101</cusip>
<value>4602</value>
<shrsOrPrnAmt>
<sshPrnamt>55156</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>55156</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>BLACK DIAMOND THERAPEUTICS I</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>09203E105</cusip>
<value>535</value>
<shrsOrPrnAmt>
<sshPrnamt>44000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>44000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Bluebird Bio Inc</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>09609G100</cusip>
<value>351</value>
<shrsOrPrnAmt>
<sshPrnamt>11000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>11000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Blueprint Medicines Corp</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>09627Y109</cusip>
<value>1715</value>
<shrsOrPrnAmt>
<sshPrnamt>19500</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>19500</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>CHEMOCENTRYX INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>16383L106</cusip>
<value>483</value>
<shrsOrPrnAmt>
<sshPrnamt>36100</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>36100</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>CHINOOK THERAPEUTICS INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>16961L106</cusip>
<value>2412</value>
<shrsOrPrnAmt>
<sshPrnamt>170821</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>170821</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>CRISPR THERAPEUTICS AG</nameOfIssuer>
<titleOfClass>NAMEN AKT</titleOfClass>
<cusip>16383L106</cusip>
<value>3560</value>
<shrsOrPrnAmt>
<sshPrnamt>22000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>22000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer> DECIPHERA PHARMACEUTICALS INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>24344T101</cusip>
<value>3661</value>
<shrsOrPrnAmt>
<sshPrnamt>100000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>100000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>DYNE THERAPEUTICS INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>26818M108</cusip>
<value>2840</value>
<shrsOrPrnAmt>
<sshPrnamt>135000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>135000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>ENANTA PHARMACEUTICALS INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>29251M106</cusip>
<value>1498</value>
<shrsOrPrnAmt>
<sshPrnamt>34047</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>34047</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>ESPERION THERAPEUTICS INC NE</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>29664W105</cusip>
<value>201</value>
<shrsOrPrnAmt>
<sshPrnamt>9500</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>9500</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Exact Sciences Corp</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>30063P105</cusip>
<value>1328</value>
<shrsOrPrnAmt>
<sshPrnamt>10700</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>10700</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Exelixis Inc</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>30161Q104</cusip>
<value>1850</value>
<shrsOrPrnAmt>
<sshPrnamt>101534</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>101534</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>FibroGen Inc</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>31572Q808</cusip>
<value>525</value>
<shrsOrPrnAmt>
<sshPrnamt>19700</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>19700</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>GAMIDA CELL LTD</nameOfIssuer>
<titleOfClass>SHS</titleOfClass>
<cusip>M47364100</cusip>
<value>682</value>
<shrsOrPrnAmt>
<sshPrnamt>107000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>107000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Gilead Sciences Inc</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>375558103</cusip>
<value>27724</value>
<shrsOrPrnAmt>
<sshPrnamt>402784</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>402784</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>GLOBAL BLOOD THERAPEUTICS IN</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>37890U108</cusip>
<value>763</value>
<shrsOrPrnAmt>
<sshPrnamt>21800</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>21800</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>GUARDANT HEALTH INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>40131M109</cusip>
<value>2112</value>
<shrsOrPrnAmt>
<sshPrnamt>17000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>17000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Halozyme Therapeutics Inc</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>40637H109</cusip>
<value>3752</value>
<shrsOrPrnAmt>
<sshPrnamt>82633</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>82633</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>HARMONY BIOSCIENCES HLDGS IN</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>413197104</cusip>
<value>4686</value>
<shrsOrPrnAmt>
<sshPrnamt>166000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>166000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>HORIZON THERAPEUTICS PUB LTD</nameOfIssuer>
<titleOfClass>SHS</titleOfClass>
<cusip>G4617B105</cusip>
<value>22274</value>
<shrsOrPrnAmt>
<sshPrnamt>237873</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>237873</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>HUTCHMED CHINA LTD</nameOfIssuer>
<titleOfClass>SPONSORED ADS</titleOfClass>
<cusip>44842L103</cusip>
<value>2671</value>
<shrsOrPrnAmt>
<sshPrnamt>68000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>68000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>I MAB</nameOfIssuer>
<titleOfClass>SPONSORED ADS</titleOfClass>
<cusip>44975P103</cusip>
<value>503</value>
<shrsOrPrnAmt>
<sshPrnamt>6000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>6000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>IMMUNOVANT INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>45258J102</cusip>
<value>634</value>
<shrsOrPrnAmt>
<sshPrnamt>60000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>60000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Incyte Corp</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>45337C102</cusip>
<value>11509</value>
<shrsOrPrnAmt>
<sshPrnamt>136860</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>136860</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>INSMED INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>457669307</cusip>
<value>2849</value>
<shrsOrPrnAmt>
<sshPrnamt>100100</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>100100</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>INTRA CELLULAR THERAPIES INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>46116X101</cusip>
<value>3243</value>
<shrsOrPrnAmt>
<sshPrnamt>79456</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>79456</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Ionis Pharmaceuticals Inc </nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>462222100</cusip>
<value>7251</value>
<shrsOrPrnAmt>
<sshPrnamt>181781</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>181781</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>IOVANCE BIOTHERAPEUTICS INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>462260100</cusip>
<value>1509</value>
<shrsOrPrnAmt>
<sshPrnamt>58000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>58000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>JAZZ PHARMACEUTICALS PLC</nameOfIssuer>
<titleOfClass>SHS USD</titleOfClass>
<cusip>G50871105</cusip>
<value>3553</value>
<shrsOrPrnAmt>
<sshPrnamt>20000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>20000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Kalvista Pharmaceuticals Inc</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>483497103</cusip>
<value>6786</value>
<shrsOrPrnAmt>
<sshPrnamt>283233</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>283233</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>MIRATI THERAPEUTICS INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>60468T105</cusip>
<value>2730</value>
<shrsOrPrnAmt>
<sshPrnamt>16900</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>16900</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>NEKTAR THERAPEUTICS</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>640268108</cusip>
<value>1149</value>
<shrsOrPrnAmt>
<sshPrnamt>67000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>67000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Neurocrine Biosciences Inc</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>64125C109</cusip>
<value>20127</value>
<shrsOrPrnAmt>
<sshPrnamt>207000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>207000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>NKARTA INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>65487U108</cusip>
<value>2214</value>
<shrsOrPrnAmt>
<sshPrnamt>70000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>70000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>ORIC PHARMACEUTICALS INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>68622P109</cusip>
<value>938</value>
<shrsOrPrnAmt>
<sshPrnamt>53000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>53000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>PROTAGONIST THERAPEUTICS INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>74366E102</cusip>
<value>6813</value>
<shrsOrPrnAmt>
<sshPrnamt>152000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>152000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>PTC Therapuetics COM</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>69366J200</cusip>
<value>18948</value>
<shrsOrPrnAmt>
<sshPrnamt>449000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>449000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Regeneron Pharmaceuticals </nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>75886F107</cusip>
<value>20778</value>
<shrsOrPrnAmt>
<sshPrnamt>37200</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>37200</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Sarepta Therapeutics Inc</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>803607100</cusip>
<value>2450</value>
<shrsOrPrnAmt>
<sshPrnamt>31500</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>31500</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>SEAGEN INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>81181C104</cusip>
<value>22868</value>
<shrsOrPrnAmt>
<sshPrnamt>145000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>145000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>SUPERNUS PHARMACEUTICALS INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>868459108</cusip>
<value>6233</value>
<shrsOrPrnAmt>
<sshPrnamt>202436</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>202436</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>SUTRO BIOPHARMA INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>869367102</cusip>
<value>2590</value>
<shrsOrPrnAmt>
<sshPrnamt>139331</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>139331</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>TRAVERE THERAPEUTICS INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>89422G107</cusip>
<value>292</value>
<shrsOrPrnAmt>
<sshPrnamt>20000</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>20000</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>TURNING POINT THERAPEUTICS I</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>90041T108</cusip>
<value>9481</value>
<shrsOrPrnAmt>
<sshPrnamt>121541</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>121541</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>ULTRAGENYX PHARMACEUTICAL IN</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>90400D108</cusip>
<value>5731</value>
<shrsOrPrnAmt>
<sshPrnamt>60100</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>60100</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>UNIQURE NV</nameOfIssuer>
<titleOfClass>SHS</titleOfClass>
<cusip>N90064101</cusip>
<value>9705</value>
<shrsOrPrnAmt>
<sshPrnamt>315500</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>315500</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>UNITED THERAPEUTICS CORP DEL</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>91307C102</cusip>
<value>7768</value>
<shrsOrPrnAmt>
<sshPrnamt>43300</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>43300</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>Vertex Pharmaceuticals Inc</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>92532F100</cusip>
<value>13069</value>
<shrsOrPrnAmt>
<sshPrnamt>64822</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>64822</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>XENON PHARMACEUTICALS INC</nameOfIssuer>
<titleOfClass>COM</titleOfClass>
<cusip>98420N105</cusip>
<value>474</value>
<shrsOrPrnAmt>
<sshPrnamt>25500</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>25500</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
<infoTable>
<nameOfIssuer>ZAI LAB LTD</nameOfIssuer>
<titleOfClass>ADR</titleOfClass>
<cusip>98887Q104</cusip>
<value>2264</value>
<shrsOrPrnAmt>
<sshPrnamt>12800</sshPrnamt>
<sshPrnamtType>SH</sshPrnamtType>
</shrsOrPrnAmt>
<investmentDiscretion>SOLE</investmentDiscretion>
<votingAuthority>
<Sole>12800</Sole>
<Shared>0</Shared>
<None>0</None>
</votingAuthority>
</infoTable>
</informationTable>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>